Organisation: Mainstay Medical

A COMPREHENSIVE SERIES OF ARTICLES ON THIS TOPIC

business

Mainstay Medical eyeing late 2020 US commercialisation approval

Irish medical device firm Mainstay Medical is expecting, by the end of next year, a decision on whether its treatment for chronic back pain will be commercially approved for sale in the US.

business

Ambitious medical devices firm Mainstay Medical raises €30m funding

news

Catch-up with what you've missed so far today with our lunchtime briefing

business

Dublin medical device company Mainstay hopes to launch back pain product this year

business

Mainstay Medical mulls more funding moves

business

Mainstay Medical secures €13m in debt financing

Dublin-based Mainstay’s back pain trials cap a memorable year

Dublin-based medical devices company Mainstay Medical has taken the first steps towards testing what it hopes with be a revolutionary treatment for chronic back pain.

Fri, 20 Mar, 2015

Irish Stock Exchange sees steady growth in 2014

Three companies raised a total of €484m on the Irish Stock Exchange last year, as equity transactions increased by 30% over the year as the economy continues to recover.

Fri, 09 Jan, 2015

Number of trades on Irish Stock Exchange up by almost a third

The number of trades dealt on the Irish Stock Exchange (ISE) stood at 2.2m for the first half of 2014 – an increase of 32% on the same period in 2013, according to new ISE statistics published today.

Tue, 15 Jul, 2014